SIGLEC1 (CD169): a marker of active neuroinflammation in the brain but not in the blood of multiple sclerosis patients

We aimed to evaluate SIGLEC1 (CD169) as a biomarker in multiple sclerosis (MS) and Neuromyelitis optica spectrum disorder (NMOSD) and to evaluate the presence of SIGLEC1(+) myeloid cells in demyelinating diseases. We performed flow cytometry-based measurements of SIGLEC1 expression on monocytes in 8...

Descripción completa

Detalles Bibliográficos
Autores principales: Ostendorf, Lennard, Dittert, Philipp, Biesen, Robert, Duchow, Ankelien, Stiglbauer, Victoria, Ruprecht, Klemens, Bellmann-Strobl, Judith, Seelow, Dominik, Stenzel, Werner, Niesner, Raluca A., Hauser, Anja E., Paul, Friedemann, Radbruch, Helena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8119413/
https://www.ncbi.nlm.nih.gov/pubmed/33986412
http://dx.doi.org/10.1038/s41598-021-89786-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8119413/
https://www.ncbi.nlm.nih.gov/pubmed/33986412
http://dx.doi.org/10.1038/s41598-021-89786-0

Ejemplares similares